Health Care Counsel Blog
847 total results. Page 14 of 34.
Members of the industry should be on the lookout for proposed rules related to this Order and take advantage of all public comment periods.
Headlines that Matter for Companies and Executives in Regulated Industries
On July 22, 2020, the Centers for Medicare & Medicaid Services (CMS) announced new initiatives designed to protect nursing home residents from the novel coronavirus (COVID-19).
Headlines that Matter for Companies and Executives in Regulated Industries
The White House released three Executive Orders on July 24, 2020 setting forth policies that the Administration believes will “deliver lower prescription drug prices to American patients.”
Headlines that Matter for Companies and Executives in Regulated Industries
For health care providers that are out-of-network with a patient’s insurance, navigating reimbursement is a tactical imperative. The current economic environment makes it more difficult for patients to pay coinsurance, while insurers are increasingly motivated to cut expenses.
Headlines that Matter for Companies and Executives in Regulated Industries
As healthcare providers turn their attention to resuming elective surgeries and procedures, it is important that this entry into the “new normal” be undertaken with care. Health care governing boards have an essential fiduciary oversight role in this process.
Headlines that Matter for Companies and Executives in Regulated Industries
The California Privacy Rights and Enforcement Act (CPRA) has qualified for the November 3, 2020 ballot, according to a recent update by the California Secretary of State’s office.
Headlines that Matter for Companies and Executives in Regulated Industries
Pharmaceutical manufacturers and other stakeholders should submit comments on the Proposed Rule by July 20, 2020.
The FDA has just issued a Guidance on what it considers to be appropriate Current Good Manufacturing Practices (CGMPs) for Responding to COVID-19 infections in employees in drug and biological manufacturing facilities.
On June 15, 2020, the owner of several information technology companies was charged in a criminal complaint with bank fraud and for making false statements to a financial institution.
FDA’s website allows you to determine if a particular COVID-19 test has been reviewed by the FDA.
Headlines that Matter for Companies and Executives in Regulated Industries
Health Care Practice Group Co-Leader Douglas Grimm was recently quoted in a Healthcare Dive article.
On May 26, 2020, a Magistrate Judge in the US District Court for the Eastern District of Virginia ordered Capital One to turn over a digital forensic investigation report in a class action arising out of a 2019 cyber incident affecting roughly 100 million US residents.
Headlines that Matter for Companies and Executives in Regulated Industries
Health Care partner Thomas Jeffry was recently quoted in a Healthcare Risk Management article titled “COVID-19 Changes HIPAA Compliance, But Caution Necessary.”
Confirming decades of established precedent, the California Supreme Court recently concluded in Nationwide Biweekly Administration, Inc. v. Superior Court of Alameda County, that there is no right to a jury trial in Unfair Competition Law (UCL) or False Advertising Law (FAL) actions.
Join Jeff Blake, Managing Partner of Federal Compliance Solutions, and Stephanie Trunk, Health Care Partner at Arent Fox, for a Government Pricing & Pharmaceutical Reimbursement Office Hour.
Across the country, health care providers have struggled during the COVID-19 pandemic in the face of declining revenue and increased expenses.
Health Care Partner Anne Murphy was recently quoted by Bloomberg Law in an article titled “Hospitals Walk Legal Tightrope as Workers Speak Out on Virus.”